Critical Role for Stromal Interaction Molecule 1 in Cardiac Hypertrophy
Jean‐Sébastien Hulot(Inserm), Stefan Engelhardt(Heidelberg University), Bernhard Nieswandt(University of Würzburg), Youakim Saliba(Inserm), Alain Lacampagne(Inserm), Jérémy Fauconnier(Inserm), Ludovic Bénard(Inserm), Dongtak Jeong(Hanyang University), Fleur Cohen‐Aubart(Inserm), Anne‐Marie Lompré(Inserm), Roger J. Hajjar(Boston Biomedical Research Institute), Silke Mühlstedt(Inserm), Yassine Sassi(Inserm), Bernhard Laggerbauer(Inserm), Morgan Dupuis(Inserm), Sabine Merkle(Inserm), Joachim P. Schmitt(Howard Hughes Medical Institute), Attila Braun(Inserm), Aude Ouillé(Inserm), Antoine H. Chaanine(Inserm), Deepak Ramanujam(Technical University of Munich), Olivier Cazorla(Inserm), Lahouaria Hadri(Icahn School of Medicine at Mount Sinai)
Cited by 165
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787
What Is the Role of β-Adrenergic Signaling in Heart Failure?
|Circulation Research|2003|764